Harm Sleeboom
AuthID: R-00F-GEX
1
TÃTULO: Healthcare-resource utilization associated with radiation to bone across eight European countries: Results from a retrospective study Full Text
AUTORES: Roger von Moos; Jean Jacques Body; Oliver Guenther; Evangelos Terpos; Yves Pascal Acklin; Jindrich Finek; Joao Pereira; Nikos Maniadakis; Guy Hechmati; Susan Talbot; Harm Sleeboom;
PUBLICAÇÃO: 2018, FONTE: JOURNAL OF BONE ONCOLOGY, VOLUME: 10
AUTORES: Roger von Moos; Jean Jacques Body; Oliver Guenther; Evangelos Terpos; Yves Pascal Acklin; Jindrich Finek; Joao Pereira; Nikos Maniadakis; Guy Hechmati; Susan Talbot; Harm Sleeboom;
PUBLICAÇÃO: 2018, FONTE: JOURNAL OF BONE ONCOLOGY, VOLUME: 10
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: Symptomatic skeletal events (SSEs) versus skeletal- related events (SREs) in patients with advanced cancer and bone metastases treated with denosumab or zoledronic acid
AUTORES: von Moos, R; Costa, LAM; Scagliotti, G; Sleeboom, H; Goldwasser, F; Hirsh, V; Spencer, A; Radcliffe, HS; Niepel, D; Henry, DH;
PUBLICAÇÃO: 2016, FONTE: ANNALS OF ONCOLOGY, VOLUME: 27
AUTORES: von Moos, R; Costa, LAM; Scagliotti, G; Sleeboom, H; Goldwasser, F; Hirsh, V; Spencer, A; Radcliffe, HS; Niepel, D; Henry, DH;
PUBLICAÇÃO: 2016, FONTE: ANNALS OF ONCOLOGY, VOLUME: 27
INDEXADO EM: Scopus WOS
Scopus WOS3
TÃTULO: Ras Inhibition and the Survival Benefit Favoring Zoledronic Acid Compared With Denosumab in Patients With Multiple Myeloma Reply
AUTORES: David H Henry; Luis Costa; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 19
AUTORES: David H Henry; Luis Costa; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 19
INDEXADO EM: Scopus WOS
Scopus WOS4
TÃTULO: Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
AUTORES: David H Henry; Luis Costa ; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 9
AUTORES: David H Henry; Luis Costa ; Francois Goldwasser; Vera Hirsh; Vania Hungria; Jana Prausova; Giorgio Vittorio Scagliotti; Harm Sleeboom; Andrew Spencer; Saroj Vadhan Raj; Roger von Moos; Wolfgang Willenbacher; Penella J Woll; Jianming M Wang; Qi Jiang; Susie Jun; Roger Dansey; Howard Yeh;
PUBLICAÇÃO: 2011, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 29, NÚMERO: 9
INDEXADO EM: WOS 
CrossRef
WOS CrossRef